| | Model 1 | Model 2 | Model 3 | Model 4 |
|---|
FEV1 |
Sarcopenia(no vs yes) | 0.75(0.57, 1.01) | 0.75(0.50, 1.12) | 0.80(0.53, 1.20) | 0.81(0.53, 1.22) |
FEV1/FVC < 0.7 |
Sarcopenia(no vs yes) | 5.44(2.25, 13.19)# | 5.89(2.34, 14.82)# | 5.37(2.09, 13.80)# | 6.82(2.54, 18.34)# |
PEF |
Sarcopenia(no vs yes) | 0.87(0.82, 0.91)# | 0.87(0.83, 0.92)# | 0.89(0.85, 0.94)# | 0.86(0.82, 0.91)# |
FEF25%-75% |
Sarcopenia(no vs yes) | 0.89(0.61, 1.30) | 0.88(0.60, 1.29) | 0.96(0.66, 1.42) | 0.93(0.63, 1.38) |
- Model 1 adjusted the following variables: sex, age, region, urban/rural, married status and body mass index
- Model 2 adjusted the following variables: sex, age, region, urban/rural, married status, body mass index, alcohol, smoking, vigorous-intensity activity, moderate- intensity activity and night sleep duration
- Model 3 adjusted the following variables: sex, age, region, urban/rural, married status,body mass index, alcohol, smoking, vigorous-intensity activity, moderate- intensity activity, night sleep duration, hypertension, diabetes, angina, stroke, chronic lung diseases, and arthritis
- Model 4 adjusted the following variables: sex, age, region, urban/rural, married status, alcohol, smoking, vigorous-intensity activity, moderate-intensity activity, body mass index, night sleep duration, hypertension, diabetes, angina, stroke, chronic lung diseases, arthritis, asthma related medications and symptoms (attacks, awakenings and severe shortness of breath)
- # P < 0.01
